Showing results (1291-1300 of 3,096) with videos related to
Sort By:
Pageof 310
Expert Review of Anticancer Therapy|September 16, 2020
PARP inhibition in treatment of pancreatic cancerPascal Hammel, Chen Zhang, Julia Matile, et al.Expert Review of Anticancer Therapy|December 7, 2019
Interpretation of ceritinib clinical trial results and future combination therapy strategies for ALK-rearranged NSCLCCollin M Blakely, Jonathan W RiessExpert Review of Anticancer Therapy|January 8, 2020
Developments in predictive biomarkers for hepatocellular carcinoma therapyAndrea Casadei-Gardini, Giulia Orsi, Francesco Caputo, et al.Expert Review of Anticancer Therapy|January 7, 2020
Identifying the optimum first-line therapy in BRAF-mutant metastatic melanomaDimitrios C Ziogas, Frosso Konstantinou, Spyros Bouros, et al.Expert Review of Anticancer Therapy|March 14, 2020
Further insights into testicular germ cell tumor oncogenesis: potential therapeutic targetsPaolo Chieffi, Marco De Martino, Francesco EspositoExpert Review of Anticancer Therapy|April 1, 2020
Asbestos-related cancers: the 'Hidden Killer' remains a global threatNico van Zandwijk, Glen Reid, Arthur L FrankExpert Review of Anticancer Therapy|October 21, 2020
Ribociclib plus fulvestrant in the treatment of breast cancerPatrick Neven, Gabe S Sonke, Guy JerusalemExpert Review of Anticancer Therapy|October 12, 2020
Pembrolizumab and other immune checkpoint inhibitors in locally advanced or metastatic Merkel Cell Carcinoma: safety and efficacyAntoine Marchand, Thibault Kervarrec, Shailender Bhatia, et al.Expert Review of Anticancer Therapy|October 15, 2020
Clinical risk factors for mortality in patients with cancer and COVID-19: a systematic review and meta-analysis of recent observational studiesYang Liu, Huan Lu, Wei Wang, et al.Expert Review of Anticancer Therapy|October 19, 2020
A novel DNA methylation 10-CpG prognostic signature of disease-free survival reveal that MYBL2 is associated with high risk in prostate cancerXueying Hou, Yuelin Zhang, Siyuan Han, et al.Pageof 310